Health Care & Life Sciences » Pharmaceuticals | BLIS Technologies Ltd.

BLIS Technologies Ltd. | Balance Sheet

Fiscal year is April-March. All values NZD Thousands.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
3,652.00
2,146.00
1,209.00
1,140.00
1,134.00
999
Total Accounts Receivable
235.00
464.00
1,207.00
1,150.00
694.00
2,372
Inventories
106.00
282.00
328.00
349.00
343.00
371
Other Current Assets
45.00
73.00
56.00
97.00
89.00
224
Total Current Assets
4,038.00
2,965.00
2,800.00
2,736.00
2,260.00
3,966
Net Property, Plant & Equipment
375.00
616.00
717.00
646.00
785.00
669
Intangible Assets
2,048.00
1,668.00
1,343.00
1,118.00
843.00
566
Total Assets
6,461.00
5,249.00
4,860.00
4,500.00
3,888.00
5,201
ST Debt & Current Portion LT Debt
-
-
-
-
121.00
Accounts Payable
238.00
338.00
712.00
316.00
429.00
Other Current Liabilities
47.00
108.00
161.00
167.00
162.00
Total Current Liabilities
285.00
446.00
873.00
483.00
712.00
Long-Term Debt
-
-
-
-
169.00
Total Liabilities
285.00
446.00
873.00
483.00
881.00
Common Equity (Total)
6,176.00
4,803.00
3,987.00
4,017.00
3,007.00
Total Shareholders' Equity
6,176.00
4,803.00
3,987.00
4,017.00
3,007.00
Total Equity
6,176.00
4,803.00
3,987.00
4,017.00
3,007.00
Liabilities & Shareholders' Equity
6,461.00
5,249.00
4,860.00
4,500.00
3,888.00

About BLIS Technologies

View Profile
Address
81 Glasgow Street
Dunedin OT 9012
New Zealand
Employees -
Website http://www.blis.co.nz
Updated 07/08/2019
BLIS Technologies Ltd. engages in the development of healthcare products based on strains of bacteria that produce Bacteriocin activity. It operates in the following geographical areas: Australasia, Asia (including China), Europe, and North America. The company was founded in June 2000 and is headquartered in Dunedin, New Zealand.